期刊文献+

效用值在COPD中的应用现状及思考 被引量:1

Application Status and Thinking of Utility Value in COPD
下载PDF
导出
摘要 成本-效用分析(CUA)综合考虑了人的生命质量和生存时间,在国内外应用日趋广泛。本研究对效用值的测量方法进行了总结,并对CUA研究中存在的问题进行思考。效用值的测量有直接测量法和间接测量法,直接测量法包括刻度法(RS)、标准博弈法(SG)、时间权衡法(TTO)、人数权衡法(PTO)和量值评估法(ME)等,间接测量法通过量表调查患者对某一健康状态的偏好程度,然后采用合适的计量经济学模型构建该量表的效用值积分体系。目前,国内COPD的CUA研究中,效用值测量的理论基础尚不完善,是否存在边际递减效应尚不明确,缺乏符合我国国情的生活质量量表,对效应值的测量方法仍需规范。 Cost and utility analysis( CUA) takes life quality and survival time into comprehensive consideration and is widely applied both home and abroad. This research summarizes the measurement methods of utility value and reflects on the existing problems in research. Utility value can be tested by direct measurement including RS,SG,TTO,PTO and ME,and indirect measurement which is firstly an questionnaire investigation about the preferences on a certain health condition of the subjects,then a suitable econometrics model being established and finally the utility value integral system being constructed.Now,there are still some problems in the research about COPD- related CUA in China. The theoretical measurement basis is not perfect. It is vague about the existence of marginal decreasing effect. A life quality questionnaire in accordance with Chinese reality is still not researched out. The measurement methods of utility value need further standardization.
出处 《中国全科医学》 CAS CSCD 北大核心 2015年第8期889-892,共4页 Chinese General Practice
基金 国家自然科学基金面上项目(81473799) 国家自然科学基金青年基金项目(30772797) 河南省科技创新人才计划(144100510010)
关键词 成本-效用分析 效用值 肺疾病 慢性阻塞性 健康相关生命质量 Costs and utility analysis Utility value Pulmonary disease chronic obstructive Health-related quality of life
  • 相关文献

参考文献27

  • 1Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - revised 2011 [ EB/OL ]. http: //www. goldcopd, org/guidelines - global - strategy - for - diagnosis - management html.
  • 2GOLD Executive Committee. Global strategy for the diagnosis, management and prevention of COPD (Revised 2011 ) [ EB/OL]. http: //www. goldcopd, org.
  • 3Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population -based survey [ J ]. Am J Respir Crit Care Med, 2007, 176 (8) : 753 -760.
  • 4何权瀛,周新,谢灿茂,梁宗安,陈萍,吴昌归.慢性阻塞性肺疾病对中国部分城市患者生命质量和经济负担的影响[J].中华结核和呼吸杂志,2009,32(4):253-257. 被引量:114
  • 5Gold MR, Siegel JE, Russe LB. et al. Cost - effetlveness in health and medicine [ M]. New York: Oxford University Press, 1996.
  • 6厉以宁.西方经济学[M].北京:高等教育出版社,2003.
  • 7Torrance GW. Utility approach to measure health - related quality of life [Jl. Journal of Chronic Disease, 1987, 40 (6): 593-600.
  • 8Masala S, Magrini A, Taglieri A, et al. Chronic obstructive pulmonary disease (COPD) patients with osteoporotic vertebral compression fractures (OVCFs): improvement of pulmoaary function after percutaneous vertebroplasty ( VTP ) [ J ]. Eur Radial, 2014, 24 (7): 1577-1585.
  • 9Rutten- van Molken MP, Hoogendoom M, Lamers LM. Holistic preferences for 1 - year health profiles describing fluctuations in health: the case of chronic obstructive pulmonary disease [ J ]. 2009. 27 (6): 465-477.
  • 10伍红艳,孙利华,任晓晓,董红燕.疾病特异性生命质量量表效用值积分体系的构建方法及探讨[J].中国卫生经济,2012,31(3):7-10. 被引量:4

二级参考文献71

共引文献405

同被引文献24

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部